Upgrade to SI Premium - Free Trial

Canaccord Starts Abbvie (ABBV) at Buy, PT set at $262

April 20, 2026 4:36 PM
Canaccord analyst Gary Nachman initiates coverage on Abbvie (NYSE ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

New Coverage